Nevro Total Liabilities 2013-2024 | NVRO

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Nevro total liabilities from 2013 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Nevro total liabilities from 2013 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.

Related Stocks
Company Name	Market Cap
Thermo Fisher Scientific (TMO)	$233.5B
Intuitive Surgical (ISRG)	$174.1B
Alcon (ALC)	$48.6B
IQVIA Holdings (IQV)	$43.5B
Edwards Lifesciences (EW)	$41.3B
IDEXX Laboratories (IDXX)	$41.2B
DexCom (DXCM)	$27.9B
STERIS (STE)	$24.1B
SONOVA HOLDING (SONVY)	$21.4B
Waters (WAT)	$19.3B
Hologic (HOLX)	$18.8B
Fresenius Medical Care AG KGaA (FMS)	$12.4B
Sysmex ADR (SSMXY)	$12.4B
Teleflex (TFX)	$11.6B
Globus Medical (GMED)	$9.4B
Penumbra (PEN)	$7.3B
Glaukos (GKOS)	$6.9B
Masimo (MASI)	$6B
TransMedics (TMDX)	$5.1B
Integer Holdings (ITGR)	$4.3B
PROCEPT BioRobotics (PRCT)	$4.2B
Tandem Diabetes Care (TNDM)	$2.9B
Inari Medical (NARI)	$2.7B
LivaNova (LIVN)	$2.6B
Veracyte (VCYT)	$2.5B
Nihon Kohden (NHNKY)	$2.5B
Elekta AB (EKTAY)	$2.5B
RxSight (RXST)	$2B
Integra LifeSciences Holdings (IART)	$1.4B
Pulse Biosciences (PLSE)	$1.1B